Cart
sales@molnova.com
Gepotidacin mesylate dihydrate
CAS No. 1624306-20-2
Gepotidacin mesylate dihydrate( —— )
Catalog No. M36338 CAS No. 1624306-20-2
Gepotidacin mesylate dihydrate (GSK2140944 mesylate dihydrate) is an orally available triazaacenaphthylene antibiotic with antibacterial activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 330 | In Stock |
|
| 10MG | 566 | In Stock |
|
| 25MG | 1131 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGepotidacin mesylate dihydrate
-
NoteResearch use only, not for human use.
-
Brief DescriptionGepotidacin mesylate dihydrate (GSK2140944 mesylate dihydrate) is an orally available triazaacenaphthylene antibiotic with antibacterial activity.
-
DescriptionGepotidacin mesylate dihydrate (GSK2140944 mesylate dihydrate) is an orally available triazaacenaphthylene antibiotic with antibacterial activity. Gepotidacin mesylate dihydrate is an inhibitor of bacterial type II topoisomerase. Gepotidacin mesylate dihydrate inhibits bacterial DNA replication by blocking topoisomerase and can be used to study bacterial infection.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAutophagy
-
TargetAutophagy
-
RecptorAutophagy | Antibacterial
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1624306-20-2
-
Formula Weight580.65
-
Molecular FormulaC25H36N6O8S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCS(=O)(O)=O.O=C1N(C2)C(N3[C@@H]2CN4CCC(CC4)NCC5=NC=C(OCCC6)C6=C5)=C(N=CC3=O)C=C1.O.O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Sulfapyridine
Sulfapyridine(Dagenan) is a sulfonamide antibacterial.
-
DMXAA
A vascular disrupting agent (VDA) and competitive inhibitor of DT-diaphorase with Ki of 20 uM; activates STING dependent innate immune pathways.
-
SJFα
SJFα (SJF alpha) is a PROTAC formed by an E3 ubiquitin ligase-conjugated protein hydrolysis regulator that degrades p38α and p38δ and can be used in cancer research.
